Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

VETEX

Financiado

Cerrado

Deep Vein Thrombosis A Paradigm Change in Treatment through Drug Free Clot Remo...

Deep Vein Thrombosis A Paradigm Change in Treatment through Drug Free Clot Removal Deep Vein Thrombosis is the 3rd leading cardiovascular disease behind heart attack and stroke with 1.2M cases diagnosed each year in the EU and US. Left untreated, one third of DVT patients will be at risk of clot breaking away c... ver más

31/07/2021

Vetex Medical

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

VETEX MEDICAL LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-07-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Vetex Medical

2.49M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Smart Clot SmartClot Personalized platform for the combined evaluation... 71K€ Cerrado

OPTAVI Adjoint based OPTimization of deflection based cerebral embo... 213K€ Cerrado

MEDICAMENTO GENÉRICO ANTICOAGULANTE ORAL DIRE... MEDICAMENTO GENÉRICO ANTICOAGULANTE ORAL DIRECTO INHIBIDOR D... 467K€ Cerrado

JCI-2011-10417 ROLE OF PLATELET-PROTEIN S IN THROMBUS STABILIZATION 96K€ Cerrado

Perfuze A simple repeatable way to completely remove a clot from th... 4M€ Cerrado

FJC2019-039717-I Trombosis arterial, coagulación, patología y calcificación v... 50K€ Cerrado

Duración del proyecto: 23 meses Fecha Inicio: 2019-08-13
Fecha Fin: 2021-07-31

Líder del proyecto

VETEX MEDICAL LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Deep Vein Thrombosis is the 3rd leading cardiovascular disease behind heart attack and stroke with 1.2M cases diagnosed each year in the EU and US. Left untreated, one third of DVT patients will be at risk of clot breaking away causing a Pulmonary Embolism which has a 50% mortality rate. In addition, significant chronic complications often occur such as clot recurrence (30%), chronic limb swelling associated with Post Thrombotic Syndrome (50%), ulceration and amputation. DVT patients are usually treated with drugs. Anticoagulation therapy alone helps prevent clot extension but it does not remove the clot. Other therapies often involve long hospital stays and often require 24-72 hours in ICU due to the significant bleeding risks associated with heavier duty clot busting (Thrombolytic) drugs. The results are poor for patients with large occulsive clots and who are at risk of bleeding, and extremely expensive for healthcare providers. Vetex Medical is an early stage medical device based in Ireland that has developed a platform technology that rapidly removes high volumes of clot form the deep veins without the use of thrombolytic drugs, and so will radically challenge the inefficiencies and economics present in the current management of deep vein thrombosis. Deep Vein Thrombosis in the larger veins of the upper limb represents $600m market opportunity. Interventions in the treatment of DVT have been increasing steadily over the last number of years with growth rates of 15%. This market segment is increasingly ‘on trend’ and set to witness expedited growth over the coming years. Vetex Medical is ambitious in its’ plan to bring the FreeFlow technology to market in both Europe and the US in 2021, through completion of a Clinical Trial and through securing regulatory approvals to allow market entry. The Vetex Medical Team has the skills and experience to develop and commercialise this novel medical technology and to implement a high growth strategy.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores